Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Blood glucose, Blood glucose increased, Chills
Clinical narrative: he can feel the typical virus body aches/body aches.; Fever; GI distress; gas and diarrhea; GI distress; gas and diarrhea; GI distress; gas and diarrhea; His heart rate was a bit higher this morning than what he is used to seeing.; muscle tension at the base of his head; blood sugar was slightly elevated, about 7-8 points above what he normally tracks in the morning; muscle tension at the base of his head; Injection site tenderness and swelling; Injection site tenderness and swelling; General fatigue; generalized muscle and joint pain; generalized muscle and joint pain; Chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Lot number: ER8737) at the age of 56 years as dose 2, 0.3 ml single and administration date 11Mar2021 (Lot number: EN6204) as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "Hypertension", start date: Mar2021 (unspecified if ongoing), notes: Verbatim: Blood pressure high; "Type 2 diabetes mellitus", start date: Mar2021 (unspecified if ongoing), notes: Verbatim: Type 2 diabetes mellitus; "Abscess", start date: Mar2021 (unspecified if ongoing), notes: He had an abscess on his side with cellulitis. Was hospitalized, the abscess was drained; "who had a natural exposure to Covid in Mar2020.", start date: Mar2020 (unspecified if ongoing); "he had Covid in Mar2020", start date: Mar2020 (unspecified if ongoing); "septic infection", start date: Mar2021 (unspecified if ongoing), notes: In Mar2021 was diagnosed with a potentially life threatening septic infection. Concomitant medication(s) included: METFORMIN ER taken for diabetes mellitus, start date: 08Mar2021 (ongoing); OZEMPIC taken for diabetes mellitus, start date: Oct2021 (ongoing); LISINOPRIL taken for hypertension, start date: 08Mar2021 (ongoing). Vaccination history included: Shingrix vaccine (had many of the same side effects with Shingrix vaccines. Lot:MX2LT,Expiry:21May2021), administration date: 20Apr2019, when the patient was 55 years old, reaction(s): "Adverse event NOS"; Shingrix vaccine (had many of the same side effects with Shingrix vaccines. Lot:23JKS, Expiry:13Apr2020.), administration date: 15Jun2019, when the patient was 55 years old, reaction(s): "Adverse event NOS". The following information was reported: ABDOMINAL DISCOMFORT (non-serious), FLATULENCE (non-serious), DIARRHOEA (non-serious) all with onset 2021, outcome "unknown" and all described as "GI distress; gas and diarrhea"; HEART RATE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "His heart rate was a bit higher this morning than what he is used to seeing."; MUSCLE TIGHTNESS (non-serious), HEAD DISCOMFORT (non-serious) all with onset 2021, outcome "unknown" and all described as "muscle tension at the base of his head"; PAIN (non-serious) with onset 11Mar2021, outcome "unknown", described as "he can feel the typical virus body aches/body aches."; BLOOD GLUCOSE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "blood sugar was slightly elevated, about 7-8 points above what he normally tracks in the morning"; VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 2021, outcome "unknown" and all described as "Injection site tenderness and swelling"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "General fatigue"; ARTHRALGIA (non-serious), MYALGIA (non-serious) all with onset 2021, outcome "unknown" and all described as "generalized muscle and joint pain"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "Chills"; PYREXIA (non-serious) with onset 11Mar2021, outcome "unknown", described as "Fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of abdominal discomfort, flatulence, heart rate increased, muscle tightness, pain, blood glucose increased, head discomfort, vaccination site swelling, vaccination site pain, fatigue, arthralgia, myalgia, chills, pyrexia, diarrhoea.  Additional Information: For concomitant drug metformin ER dosage has changed over the course of managing the disease; for ozempic dosage started at 0.25mg once a week, then was increased to 0.5mg once a week and Lisinopril dosage might have started a little lower. The patient stated that, he had Covid in Mar2020. He wasn't able to get tested in Mar2020, but he had an antibody test in Jul2020 that confirmed he had it. He stted that he had a noticeably stronger immune response with the Covid and Shingrix vaccines than with any other vaccine. The patient with the 1st dose of the Covid 19 vaccine, felt fever and body aches within 6 hours after getting the dose and went to bed early that night. He had noticeable side effects for 12-18 hours after they started at 6 pm that night. The patient did not administer any vaccines on same date with the Pfizer vaccine on same date with the Pfizer vaccine considered as suspect. He was not hospitalized for AE. Family medical history relevant to AE was none. The patient stated that, he was on long acting and short insulin, but he just got off the short acting insulin as of Sep2021. No further details provided.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101723762 same reporter/patient/product, different dose/event.